Goldman Sachs Reaffirms Buy Rating for Gossamer Bio with Revised Price Target
Goldman Sachs reaffirms its Buy rating for Gossamer Bio (NASDAQ: GOSS) on March 6, 2024, with a revised price target ...
© 2024 Stocks Today
Tag: GOSS
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape